217 related articles for article (PubMed ID: 9188099)
61. Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.
Gilboa L; Wells RG; Lodish HF; Henis YI
J Cell Biol; 1998 Feb; 140(4):767-77. PubMed ID: 9472030
[TBL] [Abstract][Full Text] [Related]
62. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor.
Gouédard L; Chen YG; Thevenet L; Racine C; Borie S; Lamarre I; Josso N; Massague J; di Clemente N
J Biol Chem; 2000 Sep; 275(36):27973-8. PubMed ID: 10854429
[TBL] [Abstract][Full Text] [Related]
63. Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.
Gebken J; Feydt A; Brinckmann J; Notbohm H; Müller PK; Bätge B
J Endocrinol; 1999 Jun; 161(3):503-10. PubMed ID: 10334821
[TBL] [Abstract][Full Text] [Related]
64. An emerging complexity of receptors for transforming growth factor-beta.
Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
[TBL] [Abstract][Full Text] [Related]
65. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
[TBL] [Abstract][Full Text] [Related]
66. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
67. Activation of a serine/threonine kinase signaling pathway by transforming growth factor type beta.
Atfi A; Lepage K; Allard P; Chapdelaine A; Chevalier S
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12110-4. PubMed ID: 8618854
[TBL] [Abstract][Full Text] [Related]
68. Analysis of signals and functions of the chimeric human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells and transgenic mice.
Watanabe S; Aoki Y; Nishijima I; Xu M; Arai K
J Immunol; 2000 Apr; 164(7):3635-44. PubMed ID: 10725720
[TBL] [Abstract][Full Text] [Related]
69. Expression of transforming growth factor-beta superfamily receptors in developing rat eyes.
Yamada H; Obata H; Kaji Y; Yamashita H
Jpn J Ophthalmol; 1999; 43(4):290-4. PubMed ID: 10482474
[TBL] [Abstract][Full Text] [Related]
70. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.
Vivien D; Bernaudin M; Buisson A; Divoux D; MacKenzie ET; Nouvelot A
J Neurochem; 1998 Jun; 70(6):2296-304. PubMed ID: 9603194
[TBL] [Abstract][Full Text] [Related]
71. Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11.
Mitchell H; Choudhury A; Pagano RE; Leof EB
Mol Biol Cell; 2004 Sep; 15(9):4166-78. PubMed ID: 15229286
[TBL] [Abstract][Full Text] [Related]
72. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
[TBL] [Abstract][Full Text] [Related]
73. Identification of a functional binding site for activin on the type I receptor ALK4.
Harrison CA; Gray PC; Koerber SC; Fischer W; Vale W
J Biol Chem; 2003 Jun; 278(23):21129-35. PubMed ID: 12665502
[TBL] [Abstract][Full Text] [Related]
74. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
[TBL] [Abstract][Full Text] [Related]
75. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts.
Mori Y; Hatamochi A; Arakawa M; Ueki H
Arch Dermatol Res; 1998 Mar; 290(3):158-62. PubMed ID: 9558492
[TBL] [Abstract][Full Text] [Related]
76. Expression of transforming growth factor-beta superfamily receptors in rat eyes.
Obata H; Kaji Y; Yamada H; Kato M; Tsuru T; Yamashita H
Acta Ophthalmol Scand; 1999 Apr; 77(2):151-6. PubMed ID: 10321529
[TBL] [Abstract][Full Text] [Related]
77. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
Nørgaard P; Spang-Thomsen M; Poulsen HS
Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
[TBL] [Abstract][Full Text] [Related]
78. TGF-betas and TGF-beta receptors in atherosclerosis.
McCaffrey TA
Cytokine Growth Factor Rev; 2000; 11(1-2):103-14. PubMed ID: 10708958
[TBL] [Abstract][Full Text] [Related]
79. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
[TBL] [Abstract][Full Text] [Related]
80. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.
Wrana JL; Tran H; Attisano L; Arora K; Childs SR; Massagué J; O'Connor MB
Mol Cell Biol; 1994 Feb; 14(2):944-50. PubMed ID: 8289834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]